MindMaze Therapeutics Holding SA (SWX: MMTX)
Salud · Biotecnología · CH
0,14 CHF
-5,55 % hoy · -92,7 % 1 año
MindMaze Therapeutics Holding SA (SWX: MMTX) opera en la industria de biotecnología dentro del sector salud. Su valor en bolsa es de 28,43 M $ y tiene 10 empleados.
En los últimos doce meses la acción ha bajado un 92,7 % y ha cotizado entre 0,13 y 2,92.
Tweenvest puntúa a MindMaze Therapeutics Holding SA en cuatro factores: calidad 58/100. Su punto más fuerte es calidad.
Evolución de la cotización de MMTX
Cifras clave
- Capitalización
- 28,43 M $
- Ingresos (últ. 12 m)
- 1,48 M $
- PER
- —
- BPA
- -0,48
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 2,92 CHF
- Mínimo 52 semanas
- 0,13 CHF
- Volumen medio (3 m)
- —
- Acciones en circulación
- 169,99 M
- Empleados
- 10
- Próximos resultados
- —
Sobre MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson’s therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
- ISIN
- CH1251125998
- Fundada en
- 2012
- Cotiza desde
- 15 dic 2025
- Bolsa
- SIX Swiss Exchange
- Divisa
- CHF
Otras empresas de biotecnología
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Mendus AB (publ)OM: IMMU | 28,73 M $ | 4,49 Skr | -8,37 % |
| Poltreg S.A.WSE: PTG | 28,68 M $ | 19,30 zł | +0,78 % |
| Biomark Diagnostics Inc.DB: 20B | 28,67 M $ | 0,24 € | 0,00 % |
| Pelthos Therapeutics Inc.NYSEAM: PTHS | 28,48 M $ | 7,44 $ | -7,35 % |
| Amplia Therapeutics LimitedASX: ATX | 28,42 M $ | 0,08 AU$ | -1,20 % |
| Microbix Biosystems Inc.TSX: MBX | 28,29 M $ | 0,30 CA$ | +1,72 % |
| Edesa Biotech, Inc.NasdaqCM: EDSA | 28,10 M $ | 2,08 $ | -6,31 % |
| ProMIS Neurosciences, Inc.NasdaqCM: PMN | 28,07 M $ | 3,13 $ | -2,49 % |